Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
528 participants
INTERVENTIONAL
2012-04-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a New HIV Prevention Intervention for Black Bisexually-active Men
NCT01347164
MySTYLE: Online Family-based HIV Prevention for Non-heterosexual Black Adolescent Males in the South
NCT03487796
A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With Men
NCT00691496
Men of African American Legacy Empowering Self
NCT01492530
Black Men Evolving Behavioral HIV Prevention Intervention for Black MSM
NCT01722838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV prevention groups
Participants randomly assigned to the MyLife Intervention arm receive three 1.5-hour HIV behavioral risk-reduction group sessions over a 1-3 week period.
MyLife MyStyle group-level intervention
Three 1.5-hour HIV behavioral risk-reduction group sessions conducted with up to 12 young African American/Black men (ages 18-29 years) over a 1-3 week period.
Wait-list control
Participants randomly assigned to the Wait-list Control arm receive the MyLife MyStyle group sessions once they have completed a 6-month follow-up assessment.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MyLife MyStyle group-level intervention
Three 1.5-hour HIV behavioral risk-reduction group sessions conducted with up to 12 young African American/Black men (ages 18-29 years) over a 1-3 week period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Identify as male
* Age 18 to 29 years
* Reside within Los Angeles County
* Self-reported anal sex with a male partner in the past 12 months
* Has not participated in an HIV prevention intervention in the past 3 months
* Able to complete ACASI and MyLife sessions in English
Exclusion Criteria
* Plan to move out of Los Angeles County before the end of their follow-up period (within 7 months)
18 Years
29 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
In The Meantime Men's Group, Inc.
OTHER
Los Angeles County Department of Public Health
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Trista Bingham, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Los Angeles County Department of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
In The Meantime Men's Group, Inc.
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1 U01SP001573-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.